Clinical Trial Update: Exparel Use in Adductor Canal Block After Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Exparel for adductor canal block after total knee arthroplasty completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis of the Knee
• Opioid-related Disorder
• Pain Postoperative

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: St. Luke's Hospital, Pennsylvania | Conditions: Arthritis Knee, Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2022-05-20